View Article

  • Over-Dieting and Excessive Dietary Restriction Pathophysiological Mechanisms, Pharmacological Perspectives, and Their Role in Metabolic and Systemic Diseases - A Comprehensive Review

  • 1,2Columbia Institute of Pharmacy, Tekari, Near Vidhansabha Road, Raipur-493111, Chhattisgarh, India

    3Sant Gahira Guru Vishwavidyalaya Sarguja Ambikapur, (C.G.), India 497001

    4Sita Ram Kashyap College of Pharmacy, Rahod, Janjgir Champa, Chhattisgarh, 495556, Chhattisgarh, India

Abstract

Background: While structured caloric restriction can improve metabolic health, excessive or prolonged dietary restriction (“over-dieting”) is increasingly prevalent due to aesthetic, social, and clinical pressures. Emerging evidence indicates that chronic energy deprivation may paradoxically exacerbate metabolic dysfunction and promote multisystem pathology Objective: This review critically evaluates the pathophysiological mechanisms, endocrine adaptations, pharmacological implications, and systemic consequences of excessive dietary restriction, integrating narrative synthesis with systematic trend-based evaluation (2020–2025).Methods: A structured literature search was conducted in PubMed, Scopus, and Web of Science (January 2020–January 2025). Keywords included “caloric restriction,” “over-dieting,” “metabolic adaptation,” “hypothalamic dysfunction,” “HPA axis,” “insulin resistance,” “gut microbiome,” and “nutritional deficiency.” Inclusion criteria comprised peer-reviewed human and translational studies. Data were synthesized thematically.Results: Excessive caloric restriction induces adaptive thermogenesis, neuroendocrine dysregulation (HPT, HPA, HPG axes), mitochondrial stress, micronutrient deficiencies, and gut microbiome alterations. These alterations contribute to metabolic inflexibility, sarcopenia, reproductive dysfunction, cardiovascular remodeling, neuropsychiatric disturbances, and immune suppression. Pharmacological agents such as GLP-1 receptor agonists and appetite suppressants may exacerbate nutrient deficits when combined with extreme restriction.Conclusion: Over-dieting represents a clinically under-recognized contributor to metabolic and systemic disease. Personalized, physiologically aligned dietary strategies and careful pharmacological monitoring are essential to prevent long-term harm

Keywords

Caloric restriction; Adaptive thermogenesis; Endocrine dysfunction; Gut microbiome; Insulin resistance

Introduction

Caloric restriction has historically been associated with longevity benefits and metabolic improvements. However, the global rise in restrictive dieting behaviors-driven by obesity epidemics, social media aesthetics and pharmacologically assisted weight loss-has led to an increase in excessive or prolonged dietary restriction beyond physiological thresholds.(1) Recent epidemiological trends indicate that up to 40-60% of adults engage in repeated dieting cycles, often involving severe caloric deficits (<800-1,000 kcal/day) without clinical supervision.(2,3) While short-term weight loss may occur, accumulating evidence suggests paradoxical metabolic consequences including adaptive thermogenesis, endocrine suppression and metabolic inflexibility.(4) This review synthesizes emerging data (2020-2025) to elucidate the mechanistic basis and systemic implications of over-dieting.(5)

2. Methodology

2.1 Search Strategy

A systematic trend-based literature search was performed across PubMed/MEDLINE, Scopus, and Web of Science to identify relevant studies published between January 2020 and January 2025. Boolean search strategies combined key terms including:(6)

  • “excessive caloric restriction” or “chronic energy deficiency”
  • “adaptive thermogenesis” and “dieting”
  • “HPA axis” and “caloric restriction”
  • “GLP-1 agonists” and “nutritional deficiency”
  • “gut microbiome” and “low calorie diet”
  • “sarcopenia” AND “diet-induced weight loss”

2.2 Inclusion Criteria:

  • Human clinical studies
  • Meta-analyses and systematic reviews
  • Translational mechanistic studies
  • English-language peer-reviewed publications

2.3 Exclusion Criteria

  • Animal-only lifespan studies without translational relevance
  • Non-peer-reviewed reports
  • Pre-2020 literature (unless foundational)

3. Pathophysiological Mechanisms of Over-Dieting

3.1 Adaptive Thermogenesis and Metabolic Suppression

Severe caloric restriction induces a disproportionate decline in resting energy expenditure (REE) that exceeds the reduction expected from weight loss alone, a phenomenon termed adaptive thermogenesis.(7) This metabolic adaptation is characterized by decreased circulating triiodothyronine (T3) concentrations, attenuation of sympathetic nervous system activity and alterations in mitochondrial efficiency that collectively reduce energy expenditure.(8) When sustained over time this suppressed metabolic state enhances energetic efficiency and predisposes individuals to accelerated fat accumulation and weight regain upon refeeding.(9)

3.2 Hypothalamic-Pituitary-Thyroid (HPT) Axis Dysregulation

Prolonged caloric restriction decreases leptin signaling, which in turn suppresses TRH and TSH secretion along the hypothalamic-pituitary-thyroid axis.(10) This suppression can lead to low T3 syndrome and symptoms such as cold intolerance, bradycardia, and fatigue; if sustained, it may resemble subclinical hypothyroidism due to persistent HPT axis suppression.(11)

3.3 Hypothalamic-Pituitary-Adrenal (HPA) Axis Activation

Energy deprivation stimulates sustained activation of the hypothalamic-pituitary-adrenal axis, leading to increased cortisol secretion. Elevated cortisol promotes central adiposity, enhances skeletal muscle proteolysis, induces insulin resistance and accelerates bone resorption. Consequently, persistent hypercortisolemia during chronic caloric restriction may contribute to the emergence of metabolic syndrome-like characteristics and broader systemic metabolic dysregulation.(12)

3.4 Reproductive Axis Suppression (HPG)

Reduced circulating leptin and insulin levels during prolonged energy deficiency disrupt hypothalamic gonadotropin-releasing hormone (GnRH) pulsatility, leading to suppression of the hypothalamic-pituitary-gonadal (HPG) axis. Clinically, this manifests as amenorrhea in females, decreased testosterone levels in males, impaired fertility and progressive reductions in bone mineral density. This constellation of findings closely parallels the pathophysiology of functional hypothalamic hypogonadism associated with chronic energy imbalance.(13)

3.5 Mitochondrial Dysfunction and Oxidative Stress

Excess restriction may reduce mitochondrial biogenesis and increase ROS production due to nutrient insufficiency, impairing metabolic flexibility.(14)

    1. Gut Microbiome Alterations

Very-low-calorie diets reduce microbial diversity and short-chain fatty acid production, affecting: Immune regulation, Insulin sensitivity, Gut barrier integrity.(15)

3.7 Micronutrient Deficiencies

Prolonged excessive dietary restriction is frequently associated with deficiencies in essential micronutrients, including iron, vitamin B12, vitamin D, zinc, and essential fatty acids. These deficiencies contribute to clinically significant consequences such as iron-deficiency anaemia, peripheral neuropathy, impaired immune competence, reduced bone mineralization and accelerated sarcopenia, thereby compounding the systemic impact of chronic energy deprivation.(16)

 4. Systemic Consequences

4.1 Metabolic Disease Risk

Paradoxically, severe dietary restriction may exacerbate metabolic dysfunction by increasing insulin resistance, promoting preferential visceral fat regain  and reducing lean body mass, thereby adversely altering body composition despite reduced caloric intake.(17)

4.2 Cardiovascular Effects

Severe and prolonged energy restriction can produce significant cardiovascular complications, including reduced cardiac muscle mass due to myocardial atrophy, electrolyte imbalances that impair normal cardiac conduction and-particularly in extreme cases-QT interval prolongation, increasing the risk of arrhythmias and sudden cardiac events.(18)

4.3 Neuropsychiatric Implications

Chronic energy restriction is associated with significant neuropsychological disturbances, including heightened anxiety and depressive symptoms, cognitive impairment and the development of obsessive, food-focused behaviors that reinforce maladaptive eating patterns.(19)

5. Pharmacological Perspectives

5.1 GLP-1 Receptor Agonists

Although effective for obesity management, combining such therapy with extreme dietary restriction may increase the risk of excessive lean mass loss, micronutrient deficiencies and Hypoglycemia in susceptible individuals.(20)

5.2 Appetite Suppressants and Sympathomimetics

Appetite suppressants and sympathomimetic agents may aggravate physiological stress responses by elevating cortisol levels and worsening electrolyte imbalances, thereby increasing the risk of metabolic and cardiovascular complications.(21)

5.3 Metformin and SGLT2 Inhibitors

In undernourished individuals, the use of metformin and SGLT2 inhibitors may further exacerbate existing energy deficits and, although uncommon, increase the risk of ketoacidosis, particularly in metabolically vulnerable patients.(22)

6. Figures (Conceptual Diagrams)

(Figure 1 illustrates the integrated neuroendocrine cascade triggered by chronic caloric deficit. Prolonged energy restriction reduces adipose tissue mass and circulating leptin levels, leading to hypothalamic dysregulation. This central adaptation disrupts three major endocrine axes: suppression of the hypothalamic-pituitary-thyroid (HPT) axis, activation of the hypothalamic–pituitary–adrenal (HPA) axis and suppression of the hypothalamic-pituitary-gonadal (HPG) axis. Collectively these hormonal alterations drive widespread systemic consequences, including metabolic suppression, insulin resistance, sarcopenia and bone loss. Figure 2 presents a systemic impact model of prolonged dietary restriction, highlighting the bidirectional interactions between central neuroendocrine adaptations and peripheral organ systems. Dietary restriction initiates hypothalamic-mediated alterations, including activation of the HPA axis and suppression of the HPT and HPG axes, resulting in elevated cortisol, reduced thyroid hormone (T3), decreased sex hormones and increased inflammatory signaling. These central changes propagate to multiple organs, contributing to muscle loss and impaired anabolic signaling, bone loss and reduced density, hepatic metabolic alterations, gut atrophy and dysbiosis, and cardiac atrophy with diminished contractile function. The figure emphasizes the integrated, multisystem nature of chronic energy deficiency.)

 

 

 

 

 

Figure 1: Neuroendocrine Cascade in Excessive Caloric Restriction

 

[Schematic representation of the neuroendocrine adaptations to chronic caloric deficit. Prolonged energy restriction reduces adipose tissue mass and circulating leptin levels, leading to hypothalamic dysregulation. This central disruption alters three major endocrine axes: suppression of the hypothalamic-pituitary-thyroid (HPT) axis resulting in decreased triiodothyronine (T3), reduced metabolic rate and diminished thermogenesis; activation of the hypothalamic-pituitary-adrenal (HPA) axis characterized by elevated cortisol, enhanced proteolysis, and central fat redistribution; and suppression of the hypothalamic-pituitary-gonadal (HPG) axis leading to reduced gonadotropin secretion, decreased sex hormones, and impaired fertility. Collectively, these neuroendocrine alterations contribute to multisystem systemic effects, including metabolic suppression, insulin resistance, sarcopenia, and bone loss.]

Description: Flow diagram showing caloric deficit → leptin reduction → HPT, HPA, HPG axis dysregulation → systemic effects.
Caption: Integrated neuroendocrine response to chronic energy deficiency.

 

 

 

Figure 2: Systemic Impact Model of Prolonged Dietary Restriction

 

[Schematic illustration of the multisystem effects of chronic dietary restriction. Central neuroendocrine adaptations-characterized by activation of the HPA axis (↑ cortisol) and suppression of the HPT and HPG axes (↓ T3, ↓ sex hormones, ↑ inflammation)-mediate downstream effects across peripheral organs. These include muscle loss and reduced anabolic signaling, bone loss and decreased bone density, impaired hepatic metabolism, gut atrophy and dysbiosis and cardiac atrophy with reduced contractility. Arrows indicate bidirectional interactions between central and peripheral systems.]

Description: Multiorgan interaction map (brain, muscle, bone, gut, liver, heart).
Caption: Multisystem consequences of prolonged dietary restriction.

7. Tables

 

Table 1: Mechanistic Overview of Over-Dieting

Mechanism

Molecular Mediators

Clinical Outcome

ReF.

Adaptive thermogenesis

↓T3, ↓SNS

Weight regain

(23)

HPA activation

↑Cortisol

Muscle loss

(24)

HPG suppression

↓GnRH

Amenorrhea

(25)

Microbiome shift

↓SCFA

Insulin resistance

(26)

 

Table 2. Pharmacological Interactions

 

Drug Class

Benefit

Risk in Over-Dieting

Ref.

GLP-1 agonists

Appetite reduction

Lean mass loss

 

(27)

SGLT2 inhibitors

Glycemic control

Ketoacidosis risk

Metformin

Insulin sensitization

GI malabsorption

 

8. Abbreviations

BMI - Body Mass Index

GLP-1 - Glucagon-Like Peptide-1

GnRH - Gonadotropin-Releasing Hormone

HPA Axis -Hypothalamic–Pituitary–Adrenal Axis

HPG Axis - Hypothalamic–Pituitary–Gonadal Axis

HPT Axis -Hypothalamic–Pituitary–Thyroid Axis

QT Interval - Interval Between Q Wave and T Wave on Electrocardiogram

REE-Resting Energy Expenditure

ROS - Reactive Oxygen Species

SCFA - Short-Chain Fatty Acids

SGLT2 - Sodium-Glucose Cotransporter-2

SNS - Sympathetic Nervous System

T3 - Triiodothyronine

TRH - Thyrotropin-Releasing Hormone

TSH - Thyroid-Stimulating Hormone

9. Future Perspectives and Research Gaps

  • Longitudinal human studies on extreme dieting patterns
  • Lean mass preservation strategies
  • Biomarkers for adaptive thermogenesis
  • Microbiome-targeted therapeutic interventions
  • Safe integration of anti-obesity pharmacotherapy

CONCLUSION

Excessive dietary restriction induces complex neuroendocrine adaptations that may paradoxically predispose individuals to metabolic dysfunction and systemic disease. While caloric restriction remains a powerful therapeutic tool, its overuse without physiological alignment carries substantial risks. Clinical practice must transition from aggressive weight-loss paradigms toward metabolically protective, individualized approaches.

Declaration:

Ethics approval and consent to participate:

This article is a narrative review and does not involve any experimental studies conducted on human participants or animals. Therefore, ethical approval and informed consent were not required.”

Clinical Trial No:

This manuscript is a review article and is not associated with any clinical trial; therefore, clinical trial registration is not applicable.

Consent for publication:

This manuscript does not include any individual participant data; therefore, consent for publication is not applicable

Availability of data and material:

Data sharing is not applicable to this article, as no datasets were generated or analyzed during the preparation of this review

Funding:

The authors received no funding for this manuscript.

Declaration of competing interest: The authors declare no conflict of interest.

 

 

Acknowledgements:

The authors express their sincere gratitude to the Principal of Columbia Institute of Pharmacy, Raipur, Chhattisgarh, India, for providing the necessary infrastructural and library facilities to support the completion of this review

REFERENCES

    1. Stewart TM, Martin CK, Williamson DA. The Complicated Relationship between Dieting, Dietary Restraint, Caloric Restriction, and Eating Disorders: Is a Shift in Public Health Messaging Warranted? Int J Environ Res Public Health. 2022 Jan 3;19(1):491.
    2. Barrea L, Caprio M, Camajani E, Verde L, Perrini S, Cignarelli A, et al. Ketogenic nutritional therapy (KeNuT)—a multi-step dietary model with meal replacements for the management of obesity and its related metabolic disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)—diet therapies in endocrinology and metabolism. J Endocrinol Invest. 2024 Jan 18;47(3):487–500.
    3. Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022 Aug;133:155217.
    4. Theodorakis N, Kreouzi M, Pappas A, Feretzakis G, Sakagianni A, Kalodanis K, et al. The Complexities of Metabolic Flexibility and Precision Approaches to Sustainable Weight Management. In: Innovations in Precision Medicine and Genomics. IGI Global; 2025. p. 133–206.
    5. Cuaranta I. Chrononutrition interventions for mental health: addressing atypical depression, ultra-processed food use disorder, and circadian dysregulation. Front Psychiatry. 2026 Jan 7;16.
    6. Ghaderi M, Moradpour F, Moaiery H, Fattahi S, Dehghanbanadaki H, Moradi Y. The Association Between Selenium Levels and Risk of Prostate Cancer: A Systematic Review and Meta-analysis of 16,964 Participants (1980–2024). Asian Pacific Journal of Cancer Prevention. 2025 Oct 1;26(10):3571–80.
    7. Nunes CL, Jesus F, Francisco R, Matias CN, Heo M, Heymsfield SB, et al. Adaptive thermogenesis after moderate weight loss: magnitude and methodological issues. Eur J Nutr. 2022 Apr 27;61(3):1405–16.
    8. Cioffi F, Giacco A, Goglia F, Silvestri E. Bioenergetic Aspects of Mitochondrial Actions of Thyroid Hormones. Cells. 2022 Mar 15;11(6):997.
    9. Christoffersen BØ, Sanchez?Delgado G, John LM, Ryan DH, Raun K, Ravussin E. Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss. Obesity. 2022 Apr 25;30(4):841–57.
    10. Barman M, Giribabu N, Salleh N. Roles of thyroid and leptin hormones and their crosstalk in male reproductive functions: an updated review. Endocrine. 2024 Oct 16;87(3):891–906.
    11. Hoermann R, Dietrich JW. Diagnosis of Hypothyroidism. In: Hypothyroidism. Singapore: Springer Nature Singapore; 2025. p. 111–32.
    12. DeFronzo RA, Auchus RJ. Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review. Diabetes. 2025 Dec 1;74(12):2168–78.
    13. Ruggiero M, Vicidomini A, Tafuri D, Mazzeo F, Meccariello R. Energy Homeostasis and Kisspeptin System, Roles of Exercise and Outcomes with a Focus on Male Reproductive Health. Endocrines. 2025 Aug 28;6(3):43.
    14. Russo L, Babboni S, Andreassi MG, Daher J, Canale P, Del Turco S, et al. Treating Metabolic Dysregulation and Senescence by Caloric Restriction: Killing Two Birds with One Stone? Antioxidants. 2025 Jan 16;14(1):99.
    15. Wang S, Bao Z, Li Z, Zhao M, Wang X, Liu F. The impact of very-low-calorie ketogenic diets on gut microbiota in individuals with obesity: a systematic review and meta-analysis. Gut Microbes. 2025 Dec 31;17(1).
    16. U?uz A, U?uz AC, Sánchez M del PT, Rodríguez Moratinos AB, Pariente Llanos JA. Micronutrients and Associated Pathologies. In 2026. p. 67–110.
    17. Janssen JAMJL. The Pivotal Role of the Western Diet, Hyperinsulinemia, Ectopic Fat, and Diacylglycerol-Mediated Insulin Resistance in Type 2 Diabetes. Int J Mol Sci. 2025 Sep 20;26(18):9191.
    18. Crintea IN, Cindrea AC, Mederle OA, Trebuian CI, Timar R. Electrolyte Imbalances and Metabolic Emergencies in Obesity: Mechanisms and Clinical Implications. Diseases. 2025 Feb 24;13(3):69.
    19. Chammas G, Hallit S, Abou Nader L, Chammas M, Fekih-Romdhane F, Obeid S, et al. Mediating effect of food disgust between depression/anxiety and avoidant restrictive eating. J Eat Disord. 2025 Oct 29;13(1):244.
    20. Al-Najim W, Raposo A, BinMowyna MN, le Roux CW. Unintended Consequences of Obesity Pharmacotherapy: A Nutritional Approach to Ensuring Better Patient Outcomes. Nutrients. 2025 Jun 5;17(11):1934.
    21. Li M, Song L, Wang J, Zhang C. Unveiling Gastrointestinal Involvement in Hypopituitarism: Clinical Features and Treatment Approaches. Clin Endocrinol (Oxf). 2025 Nov 17;103(5):641–50.
    22. JPEF 2025 ABSTRACTS. International Journal of Diabetes and Technology. 2025 Sep;4(Suppl 3):S23–43.
    23. Dulloo AG. Adaptive thermogenesis driving catch-up fat during weight regain: a role for skeletal muscle hypothyroidism and a risk for sarcopenic obesity. Rev Endocr Metab Disord. 2025 Oct 26;26(5):871–88.
    24. Nunez SG, Rabelo SP, Subotic N, Caruso JW, Knezevic NN. Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation. Int J Mol Sci. 2025 Oct 14;26(20):9994.
    25. Chapter 1 - Normal Endocrine Physiology of Hypothalamic Hormones during Ovulation, Pregnancy, and Lactation.
    26. Abbasi E, Khodadadi I. High-fat diet may increase the risk of insulin resistance by inducing dysbiosis. Metabol Open. 2025 Sep;27:100381.
    27. Gandecka-Pempera A, Naskr?t D, Adamska A, Zozuli?ska-Zió?kiewicz D. Severe euglycemic ketoacidosis following combined therapy with GLP-1 receptor agonist and SGLT-2 inhibitor, refractory to standard treatment: a case report. Front Endocrinol (Lausanne). 2025 Oct 7;16.

Reference

    1. Stewart TM, Martin CK, Williamson DA. The Complicated Relationship between Dieting, Dietary Restraint, Caloric Restriction, and Eating Disorders: Is a Shift in Public Health Messaging Warranted? Int J Environ Res Public Health. 2022 Jan 3;19(1):491.
    2. Barrea L, Caprio M, Camajani E, Verde L, Perrini S, Cignarelli A, et al. Ketogenic nutritional therapy (KeNuT)—a multi-step dietary model with meal replacements for the management of obesity and its related metabolic disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)—diet therapies in endocrinology and metabolism. J Endocrinol Invest. 2024 Jan 18;47(3):487–500.
    3. Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022 Aug;133:155217.
    4. Theodorakis N, Kreouzi M, Pappas A, Feretzakis G, Sakagianni A, Kalodanis K, et al. The Complexities of Metabolic Flexibility and Precision Approaches to Sustainable Weight Management. In: Innovations in Precision Medicine and Genomics. IGI Global; 2025. p. 133–206.
    5. Cuaranta I. Chrononutrition interventions for mental health: addressing atypical depression, ultra-processed food use disorder, and circadian dysregulation. Front Psychiatry. 2026 Jan 7;16.
    6. Ghaderi M, Moradpour F, Moaiery H, Fattahi S, Dehghanbanadaki H, Moradi Y. The Association Between Selenium Levels and Risk of Prostate Cancer: A Systematic Review and Meta-analysis of 16,964 Participants (1980–2024). Asian Pacific Journal of Cancer Prevention. 2025 Oct 1;26(10):3571–80.
    7. Nunes CL, Jesus F, Francisco R, Matias CN, Heo M, Heymsfield SB, et al. Adaptive thermogenesis after moderate weight loss: magnitude and methodological issues. Eur J Nutr. 2022 Apr 27;61(3):1405–16.
    8. Cioffi F, Giacco A, Goglia F, Silvestri E. Bioenergetic Aspects of Mitochondrial Actions of Thyroid Hormones. Cells. 2022 Mar 15;11(6):997.
    9. Christoffersen BØ, Sanchez?Delgado G, John LM, Ryan DH, Raun K, Ravussin E. Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss. Obesity. 2022 Apr 25;30(4):841–57.
    10. Barman M, Giribabu N, Salleh N. Roles of thyroid and leptin hormones and their crosstalk in male reproductive functions: an updated review. Endocrine. 2024 Oct 16;87(3):891–906.
    11. Hoermann R, Dietrich JW. Diagnosis of Hypothyroidism. In: Hypothyroidism. Singapore: Springer Nature Singapore; 2025. p. 111–32.
    12. DeFronzo RA, Auchus RJ. Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review. Diabetes. 2025 Dec 1;74(12):2168–78.
    13. Ruggiero M, Vicidomini A, Tafuri D, Mazzeo F, Meccariello R. Energy Homeostasis and Kisspeptin System, Roles of Exercise and Outcomes with a Focus on Male Reproductive Health. Endocrines. 2025 Aug 28;6(3):43.
    14. Russo L, Babboni S, Andreassi MG, Daher J, Canale P, Del Turco S, et al. Treating Metabolic Dysregulation and Senescence by Caloric Restriction: Killing Two Birds with One Stone? Antioxidants. 2025 Jan 16;14(1):99.
    15. Wang S, Bao Z, Li Z, Zhao M, Wang X, Liu F. The impact of very-low-calorie ketogenic diets on gut microbiota in individuals with obesity: a systematic review and meta-analysis. Gut Microbes. 2025 Dec 31;17(1).
    16. U?uz A, U?uz AC, Sánchez M del PT, Rodríguez Moratinos AB, Pariente Llanos JA. Micronutrients and Associated Pathologies. In 2026. p. 67–110.
    17. Janssen JAMJL. The Pivotal Role of the Western Diet, Hyperinsulinemia, Ectopic Fat, and Diacylglycerol-Mediated Insulin Resistance in Type 2 Diabetes. Int J Mol Sci. 2025 Sep 20;26(18):9191.
    18. Crintea IN, Cindrea AC, Mederle OA, Trebuian CI, Timar R. Electrolyte Imbalances and Metabolic Emergencies in Obesity: Mechanisms and Clinical Implications. Diseases. 2025 Feb 24;13(3):69.
    19. Chammas G, Hallit S, Abou Nader L, Chammas M, Fekih-Romdhane F, Obeid S, et al. Mediating effect of food disgust between depression/anxiety and avoidant restrictive eating. J Eat Disord. 2025 Oct 29;13(1):244.
    20. Al-Najim W, Raposo A, BinMowyna MN, le Roux CW. Unintended Consequences of Obesity Pharmacotherapy: A Nutritional Approach to Ensuring Better Patient Outcomes. Nutrients. 2025 Jun 5;17(11):1934.
    21. Li M, Song L, Wang J, Zhang C. Unveiling Gastrointestinal Involvement in Hypopituitarism: Clinical Features and Treatment Approaches. Clin Endocrinol (Oxf). 2025 Nov 17;103(5):641–50.
    22. JPEF 2025 ABSTRACTS. International Journal of Diabetes and Technology. 2025 Sep;4(Suppl 3):S23–43.
    23. Dulloo AG. Adaptive thermogenesis driving catch-up fat during weight regain: a role for skeletal muscle hypothyroidism and a risk for sarcopenic obesity. Rev Endocr Metab Disord. 2025 Oct 26;26(5):871–88.
    24. Nunez SG, Rabelo SP, Subotic N, Caruso JW, Knezevic NN. Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation. Int J Mol Sci. 2025 Oct 14;26(20):9994.
    25. Chapter 1 - Normal Endocrine Physiology of Hypothalamic Hormones during Ovulation, Pregnancy, and Lactation.
    26. Abbasi E, Khodadadi I. High-fat diet may increase the risk of insulin resistance by inducing dysbiosis. Metabol Open. 2025 Sep;27:100381.
    27. Gandecka-Pempera A, Naskr?t D, Adamska A, Zozuli?ska-Zió?kiewicz D. Severe euglycemic ketoacidosis following combined therapy with GLP-1 receptor agonist and SGLT-2 inhibitor, refractory to standard treatment: a case report. Front Endocrinol (Lausanne). 2025 Oct 7;16.

Photo
Shiv Kumar Bhardwaj
Corresponding author

Columbia Institute of Pharmacy, Tekari, Near Vidhansabha Road, Raipur-493111, Chhattisgarh, India

Photo
Trilochan Satapathy
Co-author

Columbia Institute of Pharmacy, Tekari, Near Vidhansabha Road, Raipur-493111, Chhattisgarh, India

Photo
Khemkaran Ahirwar
Co-author

Sant Gahira Guru Vishwavidyalaya Sarguja Ambikapur, (C.G.), India 497001

Photo
Manmohan singh Jangdey
Co-author

Sita Ram Kashyap College of Pharmacy, Rahod, Janjgir Champa, Chhattisgarh, 495556, Chhattisgarh, India

Shiv Kumar Bhardwaj, Trilochan Satapathy, Khemkaran Ahirwar, Manmohan singh Jangdey, Over-Dieting and Excessive Dietary Restriction Pathophysiological Mechanisms, Pharmacological Perspectives, and Their Role in Metabolic and Systemic Diseases - A Comprehensive Review, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 2, 3024-3032. https://doi.org/10.5281/zenodo.18697734

More related articles
Analytical Method Development and Validation by UP...
Akshada Gadakh, Monali Khatake, Reshma Lende, ...
Breaking the Solubility Barrier: The New Era of Na...
Muskan Singh Bais, Dr. Tanu Bhargava, Kamlesh Dashora, ...
Related Articles
Predictive Biomarkers and Mortality Risk in the Geriatric Population Following C...
Bipul Nath, Shahinur Islam, Subhashis Debnath, Manas Jyoti Kapil, Pranabesh Sikdar, ...
Formulation And Evaluation Of Herbal FaceWash...
Abubakar Shaikh, Tejashri Kedar , Sohel Shaikh, Aman Shaikh, Devang Shah, Harsh Meher, ...
Efficacy of Siravedha and Eranda Taila orally in Vatakantak with special referen...
Dr. Mataprasad Sharma, Dr. Aruna Sonekar, Dr. Rajendra Sonekar, ...
Analytical Method Development and Validation by UPLC...
Akshada Gadakh, Monali Khatake, Reshma Lende, ...